Curia India private limited (“the assessee”), engaged in manufacturing and contract research activities in the field of medicinal chemistry, had entered into international transactions with its Associated Enterprises. The TPO proposed transfer pricing adjustments in respect of provision of R&D Services, interest on delayed trade receivables and interest on external commercial borrowings. The assessee challenged these adjustments before the ITAT.
Assessee’s Contentions | Revenue’s Contentions | Tribunal’s Judgment |
The assessee contended that Aurigene Discovery Technologies Ltd. should be excluded from the final set of comparables, as the TPO himself had applied a 75% R&D service-income filter. Aurigene’s revenue from research services and discovery & collaboration constituted only 69.43% of its total revenue and therefore failed the filter. | The Revenue relied upon the order of the AO/TPO and supported the inclusion of Aurigene in the final set of comparables. It therefore opposed the assessee’s contention that Aurigene should be excluded for failing to satisfy the 75% R&D service-income filter. | The ITAT held that the 75% filter must be applied uniformly to all comparables. Since Aurigene derived only 69.43% of its total revenue from research services and discovery & collaboration, it failed the filter. The AO/TPO was directed to exclude Aurigene and recompute the ALP. |
The assessee submitted that interest on delayed trade receivables should be benchmarked at LIBOR + 200 basis points after a 30-day credit period. It further submitted that interest on ECBs should be benchmarked at LIBOR + 3%, following the Tribunal’s earlier decision in its own case. | It The Revenue fairly submitted that both issues were covered by the Tribunal’s decision in the assessee’s own case for AY 2018-19. No distinguishing feature was brought to the Tribunal’s notice for the year under consideration. | The ITAT directed the AO/TPO to benchmark interest on delayed trade receivables at LIBOR + 200 basis points after a 30-day credit period and interest on ECBs at LIBOR + 3%. The respective grounds were allowed for statistical purposes. |
Ruling Summary:
ITAT directed exclusion of Aurigene Discovery Technologies Ltd. from the final set of comparables as it failed the 75% R&D service-income filter applied by the TPO and directed computation of the ALP.
ITAT directed benchmarking of interest on delayed trade receivables at LIBOR + 200 basis points after a 30-day credit period and interest on ECBs at LIBOR + 3%, following its earlier decision in the assessee’s own case.

